GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
NASDAQ:EARS
Delisted

Auris Medical Holding AG Stock Price (Quote)

$0.750
-0.0010 (-0.133%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.680 $1.00 Friday, 27th May 2022 EARS stock ended at $0.750. This is 0.133% less than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 10.68% from a day low at $0.740 to a day high of $0.82.
90 days $0.635 $2.14
52 weeks $0.635 $4.58

Historical Auris Medical Holding AG prices

Date Open High Low Close Volume
2021-07-08 $3.03 $3.20 $3.01 $3.19 324 967
2021-07-07 $3.41 $3.41 $3.13 $3.20 451 120
2021-07-06 $3.63 $3.69 $3.41 $3.47 1 207 094
2021-07-02 $3.55 $3.61 $3.47 $3.58 251 042
2021-07-01 $3.61 $3.63 $3.51 $3.57 297 568
2021-06-30 $3.51 $3.60 $3.41 $3.57 426 865
2021-06-29 $3.67 $3.71 $3.49 $3.52 316 937
2021-06-28 $3.73 $3.75 $3.58 $3.66 457 265
2021-06-25 $3.48 $3.75 $3.48 $3.66 1 037 276
2021-06-24 $3.51 $3.55 $3.44 $3.52 201 952
2021-06-23 $3.39 $3.56 $3.38 $3.51 487 640
2021-06-22 $3.57 $3.57 $3.31 $3.38 857 750
2021-06-21 $3.79 $4.13 $3.45 $3.61 15 038 368
2021-06-18 $3.28 $3.40 $3.26 $3.32 388 063
2021-06-17 $3.39 $3.43 $3.30 $3.30 175 477
2021-06-16 $3.37 $3.56 $3.34 $3.44 973 699
2021-06-15 $3.56 $3.58 $3.35 $3.39 252 763
2021-06-14 $3.55 $3.59 $3.48 $3.54 645 175
2021-06-11 $3.54 $3.63 $3.50 $3.61 340 877
2021-06-10 $3.58 $3.65 $3.46 $3.48 327 694
2021-06-09 $3.60 $3.75 $3.55 $3.55 435 287
2021-06-08 $3.64 $3.66 $3.48 $3.65 552 292
2021-06-07 $3.53 $3.69 $3.50 $3.55 792 516
2021-06-04 $3.72 $3.72 $3.41 $3.47 3 199 338
2021-06-03 $3.88 $4.58 $3.61 $3.79 15 599 247
Click to get the best stock tips daily for free!

About Auris Medical Holding AG

Auris Medical Holding AG Auris Medical Holding AG, a clinical-stage biopharmaceutical company, focuses on the development of novel products for the treatment of inner ear disorders. Its lead product candidate includes AM-101, which is in Phase III clinical development for treating acute inner ear tinnitus. The company is also developing AM-111 for the treatment of acute sensorineural hearing loss; and other pre-clinical stage products comprising AM-102 and AM-123. It has... EARS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT